Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation.

Robaczyńska J, Maj M, Kiljańczyk A, Pastuszek B, Reducha E, Nurkiewicz A, Kiljańczyk M

Open source

DOI
10.3390/cancers18030389
Published
2026 Jan 27
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18030389,
  title = {Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation.},
  author = {Robaczyńska J and Maj M and Kiljańczyk A and Pastuszek B and Reducha E and Nurkiewicz A and Kiljańczyk M},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18030389},
  url = {https://doi.org/10.3390/cancers18030389}
}

RIS

TY  - JOUR
TI  - Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation.
AU  - Robaczyńska J
AU  - Maj M
AU  - Kiljańczyk A
AU  - Pastuszek B
AU  - Reducha E
AU  - Nurkiewicz A
AU  - Kiljańczyk M
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18030389
UR  - https://doi.org/10.3390/cancers18030389
ER  - 

APA

J, R., M, M., A, K., B, P., E, R., A, N., & M, K. (2026). Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation.. Cancers. https://doi.org/10.3390/cancers18030389

Source records